Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1992-03-17
1993-04-27
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
435 28, G01N 3315, C12Q 128
Patent
active
052060063
ABSTRACT:
Spontaneous aspecific coloration in so-called Trinder reagents which can alter subsequent colorimetric determinations is inhibited by adding compounds of the chelating agent class to the solution. The resultant compositions contain a peroxidase enzyme, a phenylpyrazone derivative, a compound of phenolic or aromatic amine structure and a stabilizer. Preferred stablizers are ethylenediaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA).
REFERENCES:
patent: Re29498 (1977-12-01), Meiattini
patent: 3992158 (1976-11-01), Przybylowicz
patent: 4716110 (1987-12-01), Wada et al.
Putz et al., Am. Jour. Med. Technology vol. 42(10) 1976. pp. 351-356.
Ziebig et al., "Investigations of the Effect of Ascorbic Acid on Glucose Determination in the GOD-PAP Method", Zentralbl. Pharm. 125, (1986) pp. 223-227.
D'Alterio Maurizio
Frontini Dario
Hollinden Gary E.
Instrumentation Laboratory SpA
Robinson Allen J.
LandOfFree
Stabilized trinder reagent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized trinder reagent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized trinder reagent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2325402